StonvexLoading…
StonvexStonvexStonvexCore line items from IMXI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $607.78M | $658.65M | $658.74M | $546.80M |
Operating Income | $55.65M | $95.02M | $95.49M | $82.91M |
Net Income | $32.67M | $58.82M | $59.52M | $57.33M |
EPS (Diluted) | $1.08 | $1.79 | $1.63 | $1.48 |
Total Assets | $517.69M | $462.38M | $576.81M | $512.07M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $168.68M | $130.50M | $239.20M | $149.49M |
Free Cash Flow OCF − CapEx | $15.81M | $23.09M | $130.72M | $3.00M |
Shares Outstanding | 29.72M | 30.55M | 33.82M | 36.63M |